Donald E Ward

Title: Innovator Spotlight: Donald E. Ward

Introduction

Donald E. Ward is a prominent inventor based in Palo Alto, California, known for his significant contributions to the field of biotechnology. With an impressive portfolio of seven patents, he has made remarkable strides in enzyme technology, particularly in relation to glucoamylases and alpha-amylase variants.

Latest Patents

Among his notable inventions, Donald's recent patents focus on glucoamylases that demonstrate at least 80% sequence identity to a specified aglucoamylase. These inventions encompass not only the enzymes themselves but also the DNA sequences that code for these glucoamylases, along with vectors, host cells, enzyme compositions, and various applications for their use. Additionally, he has developed compositions featuring alpha-amylase variants with altered properties, which maintain alpha-amylase activity while presenting improved functionalities compared to their parent intellectual property.

Career Highlights

Donald E. Ward has contributed to advancements in enzyme development during his tenure at renowned companies such as Danisco US Inc. and Genencor International, Inc. His work has significantly impacted both industries and academic research in enzyme utilization within multiple applications.

Collaborations

Over the years, Donald has collaborated with notable individuals in his field, including Nigel S. Dunn-Coleman and Paulien Neefe-Kruithof. These partnerships have allowed for shared knowledge and innovation, further propelling advancements in biotechnology.

Conclusion

Donald E. Ward exemplifies the spirit of innovation through his dedication to enzyme research and development. His contributions have paved the way for advancements in biotechnology, showcasing the importance of collaboration and creativity in driving scientific progress.